Shibre T, Kebede D, Alem A, Kebreab S, Melaku Z, Deyassa N, Negash A, Fekadu A, Fekadu D, Medhin G, Negeri C, Jacobsson L, Kullgren G
Department of Community Health, addis Ababa University, Ethiopia.
Nord J Psychiatry. 2002;56(6):425-31. doi: 10.1080/08039480260389343.
Several studies have reported neurological soft signs (NSS) to be common in individuals with schizophrenia. The majority of these studies are based on clinical samples exposed to neuroleptic treatment. The present study reports on 200 treatment-naïve and community-identified cases of schizophrenia and 78 healthy individuals from the same area, evaluated using the Neurological Evaluation Scale (NES). The median NES score was 5.0 for cases of schizophrenia and 1.5 for healthy subjects. The impairment rate of NSS in cases with schizophrenia was 65.0% against 50.0% in healthy subjects, and the difference was statistically significant (chi2 = 5.30; df = 1; P < 0.021). NSS abnormality is as common in treatment-naïve cases as reported in many studies in those on neuroleptic medication. There was no significant relation between the NSS impairment and duration of illness, remission status, positive symptoms, negative symptoms and disorganized symptoms.
多项研究报告称,神经系统软体征(NSS)在精神分裂症患者中很常见。这些研究大多基于接受抗精神病药物治疗的临床样本。本研究报告了200例未经治疗且来自社区的精神分裂症病例以及来自同一地区的78名健康个体,使用神经学评估量表(NES)进行评估。精神分裂症病例的NES评分中位数为5.0,健康受试者为1.5。精神分裂症患者中NSS的损害率为65.0%,而健康受试者为50.0%,差异具有统计学意义(χ² = 5.30;自由度 = 1;P < 0.021)。NSS异常在未经治疗的病例中与许多关于抗精神病药物治疗患者的研究报告一样常见。NSS损害与病程、缓解状态、阳性症状、阴性症状和紊乱症状之间没有显著关系。